Atlas Trials

A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)

Clinical trial NCT00546286 · COMPLETED

Trial details

NCT number
NCT00546286
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
GlaucomaOcular Hypertension
Start date
2006-05-31
Primary completion
2007-08-23
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.